| [Dear/Hello/Hi/Good morning/Good afternoon/Good evening/Greetings] [Dr/Doctor/Miss/Mr/Mrs/Ms] [First Name] [Last Name],
| | Thank you for your partnership and your patients’ commitment to the apitegromab clinical program.
| | ONYX Clinical Trial Information
| | As a follow-up to our recent conversation, as of [date], ISEMBYLD™ (apitegromab-mstn) has been approved by the US Food and Drug Administration (FDA). Per the ONYX clinical trial protocol, patients who wish to continue with ISEMBYLD treatment will need to transition to commercially
available product once a path to access is determined. Patients may also need to complete an end-of-treatment visit, which will serve as their end-of-study visit, before receiving their first commercial infusion. Your Clinical Research Associate will be in touch about end-of-study/end-of-treatment protocol once insurance approval is in place.
| | Our priority is to ensure uninterrupted care for patients who choose to continue treatment with ISEMBYLD. We understand that insurance approval is needed before transitioning to commercial therapy, and Scholar Rock is committed to supporting you and your team throughout this process.
| | Next Steps: Scholar Rock Supports™ Enrollment
|
Enrollment in Scholar Rock Supports will enable us to help coordinate and support appropriate patients through the transition from the ONYX clinical trial. Our program can help patients with:
| •
| Insurance access and benefits support
| | •
| Financial support and copay assistance (for eligible patients)
| | •
| Infusion day coordination (at home, in hospital, or infusion center)
| | •
| Caregiver support and resources
| | •
| Guidance on what patients can expect with treatment
|
| The Scholar Rock Supports enrollment form must be signed by the prescriber and patient, or patient's legal representative. The patient or the patient's legal representative can review, complete, and electronically sign the patient sections of the form via the
Scholar Rock eConsent portal at srrksupportsconsent.com. Once completed, it will activate support by an experienced and dedicated team including an Rx Onboarding and Care Coordinator (ROCC).
| 
| | I’ve attached a one-page, step-by-step patient transition guide for your reference. If you have transition questions, please contact [me/your ROCC]. To get started, please click the link below to download and print the Scholar Rock Supports enrollment form. Please read the instructions
on the form for how to complete and return it via fax to 877-219-0016.
| |
| |
|
|
